Multi-centre trial of aprotinin [correction of aspirin] highlights increased safety with higher dose.
D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic
D006490:Hemostatics; D007611:Aprotinin